Endocannabinoid System & Cannabis for Chronic Back Pain Trial
This phase 3 full-spectrum cannabis extract trial evaluated VER-01 for chronic low back pain in 820 adults. The study demonstrated significant pain reduction and good tolerability. These results support the potential of cannabis extract as an alternative…
Cannabinoid Efficacy in Chronic Pain: Updated Clinical Evidence
Clinical trials demonstrate cannabinoid efficacy chronic pain with modest reductions compared to placebo. The THC-to-CBD ratio and administration method influence outcomes. Patients and clinicians should consider these factors carefully.
Endocannabinoid System & PTSD: Cannabis in Dual Diagnosis
Cannabis use and trauma-focused treatment are critical considerations in managing PTSD with co-occurring substance use disorders. Evidence shows trauma-focused treatments remain effective despite cannabis use. This supports continuing evidence-based care…
Exploring Endocannabinoid System Research in Digital Mental Health
This article discusses how endocannabinoid system research meets digital mental health through a randomized controlled trial of the Minder app. The study highlights cannabis-related mental health support for university students. Digital tools offer…
Medical Cannabis Evidence-Based Care: Phase 3 Trial Results
This phase 3 cannabis trial chronic low back pain study evaluated the full-spectrum cannabis extract VER-01 in 820 adults. The trial demonstrated significant pain reduction over 12 weeks with sustained effects. These results provide important evidence…
Endocannabinoid System & Chronic Pain: Clinical Evidence Review
Clinical trials demonstrate cannabinoids for chronic pain clinical evidence with modest reductions in neuropathic and mixed pain. Benefits are often accompanied by adverse effects like dizziness and sedation. Patients and clinicians should weigh these…
Endocannabinoid System Research: Cannabis for Chronic Pain
The cannabinoids chronic pain evidence review 2025 highlights measurable but modest pain relief for chronic pain conditions. Effects vary based on THC-to-CBD ratio, cannabinoid source, and delivery method. Clinicians should weigh benefits against harms…
Study Finds Cannabis Use, Anxiety, and Depression Rising in Canada
A Canadian study highlights cannabis use anxiety treatment evidence by showing rising rates of cannabis use alongside anxiety and depression. The research reveals a consistent association between cannabis use and mood disorders. This evidence underscores…